by Annie De Groot | Jan 17, 2023 | Featured, Thinking Out Loud -Blog
At GREAT risk of dating myself, nearly 20 years ago, I flew to a meeting in an obscure hotel in Ames, Iowa to give a talk on in silico methods for vaccine design (link is to the latest publication on the tools). On the way to my room, I shared an elevator with...
by Annie De Groot | Oct 8, 2021 | Events
From October 25th to the 28th EpiVax will be represented at the Boulder Peptide Symposium in Boulder, CO by Dr. Brian Roberts, Scientific Director of Protein Therapeutics and Aimee Mattei, Immunoinformatics Program Manager, Peptide Therapeutics. Aimee and Brian will...
by Annie De Groot | Oct 8, 2021 | Events, Featured
EpiVax had a large contingent at AAPS PharmSci360 in Philadelphia! Check out the EpiVax itinerary below! Always nice to connect with our partners, clients, and friends in Philly. Annie De Groot, MD Speaker Spotlight: Engineering Better Biologics: Does Nature Know...
by Annie De Groot | Dec 31, 2020 | Featured, News
PROVIDENCE, R.I., Dec. 31, 2020 /PRNewswire/ — EpiVax (“EpiVax”) and EpiVax Therapeutics (“EVT”) today provide an update on the advancement of their peptide-based COVID-19 vaccine, EPV-CoV-19. EPV-CoV-19, a T cell epitope-based vaccine...
by Annie De Groot | Dec 29, 2020 | Featured, News
PROVIDENCE, R.I., Dec. 29, 2020 /PRNewswire/ — EpiVax, Inc. (“EpiVax”) today provides an update on the advancement of the company’s peptide therapeutic immunogenicity assessment program. The PANDA (Peptide Abbreviated New Drug Application)...
